Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Over the last 12 months, insiders at Charles River Laboratories International, Inc. have bought $1.45M and sold $11.08M worth of Charles River Laboratories International, Inc. stock.
On average, over the past 5 years, insiders at Charles River Laboratories International, Inc. have bought $1.28M and sold $33.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: FOSTER JAMES C (Chairman, President and CEO) — $1M. WALLMAN RICHARD F (director) — $795,144. Girshick Birgit (Corporate Executive VP & COO) — $248,298.
The last purchase of 1,322 shares for transaction amount of $248,298 was made by Girshick Birgit (Corporate Executive VP & COO) on 2023‑11‑20.
2024-05-15 | Sale | MASSARO GEORGE | director | 332 0.0007% | $235.62 | $78,225 | -8.66% | |
2024-05-10 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 1,304 0.0025% | $226.97 | $295,969 | -6.02% | |
2024-03-08 | Sale | Knell Michael Gunnar | CSVP&Chief Accounting Officer | 808 0.0016% | $267.52 | $216,156 | -13.44% | |
2024-03-04 | Sale | Knell Michael Gunnar | CSVP&Chief Accounting Officer | 2,750 0.0054% | $261.05 | $717,890 | -10.21% | |
2024-02-29 | Sale | Creamer Victoria L | EVP & Chief People Officer | 5,000 0.0097% | $253.70 | $1.27M | -8.50% | |
2024-02-29 | Sale | Parisotto Shannon M | CEVP, Disc & Safety Assessment | 3,786 0.0073% | $253.45 | $959,545 | -8.50% | |
2024-02-22 | Sale | Barbo William D | Corporate Executive VP & CCO | 4,050 0.0079% | $248.50 | $1.01M | -5.62% | |
2024-02-15 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 838 0.0016% | $238.93 | $200,223 | -4.14% | |
2024-02-15 | Sale | Parisotto Shannon M | CEVP, Disc & Safety Assessment | 5,882 0.0113% | $241.20 | $1.42M | -4.14% | |
2023-12-14 | Sale | Creamer Victoria L | EVP & Chief People Officer | 5,526 0.0106% | $225.00 | $1.24M | +0.96% | |
2023-11-30 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 1,850 0.0036% | $197.73 | $365,801 | +16.21% | |
2023-11-20 | Girshick Birgit | Corporate Executive VP & COO | 1,322 0.0025% | $187.82 | $248,298 | +19.36% | ||
2023-11-14 | FOSTER JAMES C | Chairman, President and CEO | 5,620 0.0109% | $178.05 | $1M | +26.73% | ||
2023-11-09 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 9,128 0.0182% | $173.48 | $1.58M | +33.63% | |
2023-08-24 | WALLMAN RICHARD F | director | 1,000 0.0019% | $198.79 | $198,786 | +8.14% | ||
2023-08-10 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 700 0.0014% | $216.52 | $151,564 | -1.50% | |
2023-08-10 | Sale | Knell Michael Gunnar | CSVP&Chief Accounting Officer | 1,471 0.0029% | $216.54 | $318,530 | -1.50% | |
2023-08-10 | Sale | Barbo William D | Corporate Executive VP & CCO | 5,763 0.0113% | $217.24 | $1.25M | -1.50% | |
2023-05-15 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 345 0.0007% | $190.39 | $65,685 | +8.55% | |
2023-05-12 | Sale | LaPlume Joseph W | EVP, Corp Strategy & Develop | 959 0.0019% | $193.03 | $185,116 | +9.09% |
FOSTER JAMES C | Chairman, President and CEO | 202643 0.395% | $206.71 | 6 | 83 | +4.13% |
Girshick Birgit | Corporate Executive VP & COO | 44449 0.0867% | $206.71 | 1 | 13 | |
LaPlume Joseph W | EVP, Corp Strategy & Develop | 23276 0.0451% | $206.71 | 0 | 19 | |
Creamer Victoria L | EVP & Chief People Officer | 13550 0.0322% | $206.71 | 0 | 3 | |
Knell Michael Gunnar | CSVP&Chief Accounting Officer | 7825 0.0194% | $206.71 | 0 | 8 | |
Parisotto Shannon M | CEVP, Disc & Safety Assessment | 4792 0.0117% | $206.71 | 0 | 4 | |
MASSARO GEORGE | director | 5855 0.0097% | $206.71 | 0 | 32 | |
Barbo William D | Corporate Executive VP & CCO | 22879 0.007% | $206.71 | 0 | 13 | |
WALLMAN RICHARD F | director | 1000 0.0019% | $206.71 | 4 | 12 | +7.27% |
CAWTHORN ROBERT | director | 286700 0.5589% | $206.71 | 0 | 2 | |
JOHST DAVID P | Corporate Executive VP | 212854 0.4149% | $206.71 | 0 | 28 | |
NIMMO WALTER S | director | 149447 0.2913% | $206.71 | 0 | 5 | |
ACKERMAN THOMAS F | 111698 0.2177% | $206.71 | 0 | 41 | ||
RENAUD REAL H | Corp. Executive VP | 63586 0.124% | $206.71 | 0 | 12 | |
REESE C RICHARD | director | 56457 0.1101% | $206.71 | 0 | 4 | |
CHUBB STEPHEN D | director | 40529 0.079% | $206.71 | 0 | 40 | |
SHAUGHNESSY DENNIS R | Sr. VP Corporate Development | 37761 0.0736% | $206.71 | 0 | 3 | |
BERTOLINI ROBERT J | director | 29134 0.0568% | $206.71 | 0 | 5 | |
MILNE GEORGE M JR | director | 28417 0.0554% | $206.71 | 0 | 10 | |
Smith David Ross | Corporate Executive VP & CFO | 27064 0.0528% | $206.71 | 0 | 28 | |
WALTRIP WILLIAM | director | 21830 0.0426% | $206.71 | 0 | 5 | |
Molho Davide | President & COO | 17155 0.0334% | $206.71 | 0 | 20 | |
BATHGATE BRIAN | Corporate Vice President | 16134 0.0315% | $206.71 | 0 | 8 | |
BERTHOUX CHRISTOPHER | Corp Sr VP | 15047 0.0293% | $206.71 | 0 | 7 | |
THIER SAMUEL O MD | director | 14190 0.0277% | $206.71 | 0 | 17 | |
GELLER JORG | Corporate Executive VP | 14094 0.0275% | $206.71 | 0 | 26 | |
URQUHART JOHN | director | 11738 0.0229% | $206.71 | 0 | 2 | |
ELLIOTT DAVID J | Officer | 11750 0.0229% | $206.71 | 0 | 1 | |
GILLETT NANCY | Corporate Executive VP | 11034 0.0215% | $206.71 | 1 | 41 | +0.49% |
Ho John C | Senior Vice President | 8950 0.0174% | $206.71 | 1 | 0 | +15.04% |
Kochevar Deborah Turner | director | 6096 0.0119% | $206.71 | 0 | 10 | |
Crowley John J | SVP, Chief Accounting Officer | 5883 0.0115% | $206.71 | 0 | 3 | |
ROGERS DOUGLAS E | director | 5349 0.0104% | $206.71 | 0 | 1 | |
ANKCORN MICHAEL F | Corp. Sr. VP | 0 0% | $206.71 | 0 | 3 | |
MCEWAN ALASTAIR STUART | Corporate VP | 0 0% | $206.71 | 0 | 3 |
The Vanguard Group | $1.64B | 11.74 | 6.05M | +1.11% | +$17.93M | 0.03 | |
BlackRock | $1.4B | 10.04 | 5.17M | +0.2% | +$2.82M | 0.03 | |
State Street | $567.4M | 4.07 | 2.09M | +1.67% | +$9.3M | 0.02 | |
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC | $508.74M | 3.65 | 1.88M | +7.09% | +$33.7M | 1.18 | |
ClearBridge Investments | $409.98M | 2.94 | 1.51M | +3.07% | +$12.21M | 0.33 | |
T. Rowe Price | $358.32M | 2.57 | 1.32M | -8.37% | -$32.71M | 0.04 | |
Geode Capital Management | $320.48M | 2.3 | 1.19M | +3.48% | +$10.77M | 0.03 | |
Meritage Group LP | $320.34M | 2.3 | 1.18M | +2.33% | +$7.29M | 7.55 | |
Allspring Global Investments | $303.14M | 2.17 | 1.12M | -3.99% | -$12.6M | 0.48 | |
Ariel Investments | $252.74M | 1.81 | 932,807 | -11.22% | -$31.94M | 2.49 | |
Mackenzie Financial Corp | $252.47M | 1.81 | 931,797 | +1.52% | +$3.78M | 0.34 | |
EARNEST Partners | $242.16M | 1.74 | 893,761 | +0.49% | +$1.19M | 1.11 | |
Invesco | $241.83M | 1.73 | 892,524 | -5.88% | -$15.12M | 0.05 | |
Bank of America | $240.92M | 1.73 | 889,170 | +20.79% | +$41.47M | 0.02 | |
Southpoint Capital Advisors Lp | $189.66M | 1.36 | 700,000 | -30% | -$81.28M | 3.75 | |
Marshall Wace | $179.6M | 1.29 | 662,849 | New | +$179.6M | 0.23 | |
Franklin Templeton Investments | $176.61M | 1.27 | 651,805 | -14.57% | -$30.13M | 0.05 | |
SEI Investments Company | $155.89M | 1.12 | 575,349 | +1.26% | +$1.94M | 0.23 | |
Wells Fargo | $154.28M | 1.11 | 569,415 | +4.38% | +$6.47M | 0.04 | |
Thrivent Financial For Lutherans | $153.32M | 1.1 | 565,864 | +27.79% | +$33.34M | 0.32 | |
Montrusco Bolton Investments Inc | $132.7M | 0.95 | 489,751 | -32.18% | -$62.95M | 1.42 | |
Dimensional Fund Advisors | $126.64M | 0.91 | 467,393 | -3.02% | -$3.94M | 0.03 | |
Fidelity Investments | $125.93M | 0.9 | 464,765 | +22.54% | +$23.16M | 0.01 | |
Victory Capital Management Inc | $124.59M | 0.89 | 459,818 | -1.66% | -$2.1M | 0.13 | |
Northern Trust | $124.43M | 0.89 | 459,251 | -4.4% | -$5.73M | 0.02 | |
Congress Asset Management Co Ma | $122.85M | 0.88 | 453,392 | -2.55% | -$3.22M | 0.89 | |
Charles Schwab | $121.6M | 0.87 | 448,809 | -12.55% | -$17.45M | 0.03 | |
Morgan Stanley | $117.88M | 0.85 | 435,059 | -7.85% | -$10.04M | 0.01 | |
Fil Ltd | $107.58M | 0.77 | 397,045 | -40.08% | -$71.97M | 0.11 | |
BNY Mellon | $104.05M | 0.75 | 384,023 | -3.17% | -$3.41M | 0.02 | |
William Blair Investment Management | $98.79M | 0.71 | 364,614 | -1.62% | -$1.62M | 0.26 | |
JPMorgan Chase | $96.03M | 0.69 | 354,428 | +55.8% | +$34.39M | 0.01 | |
Luther King Capital Management | $95.16M | 0.68 | 351,205 | -4.26% | -$4.23M | 0.43 | |
Legal & General | $87.02M | 0.62 | 321,167 | -3.17% | -$2.85M | 0.02 | |
Van Berkom Associates Inc | $84.39M | 0.61 | 311,466 | -2.18% | -$1.88M | 2.4 | |
Envestnet Asset Management Inc | $83.36M | 0.6 | 307,663 | +14.56% | +$10.59M | 0.03 | |
Riverbridge Partners | $82.31M | 0.59 | 303,778 | +1.03% | +$836,692.96 | 1.01 | |
Ameriprise Financial | $76.61M | 0.55 | 282,736 | +1,098.8% | +$70.22M | 0.02 | |
PRIMECAP Management Co | $74.22M | 0.53 | 273,930 | 0% | +$0 | 0.06 | |
Neuberger Berman | $72.28M | 0.52 | 266,823 | +3.57% | +$2.49M | 0.06 | |
Jackson Square LLC | $68.09M | 0.49 | 251,308 | -28.09% | -$26.6M | 2.83 | |
Raymond James Associates | $67.29M | 0.48 | 248,348 | +1.91% | +$1.26M | 0.05 | |
Epoch Investment Partners Inc | $67.06M | 0.48 | 247,501 | +2,733.44% | +$64.69M | 0.3 | |
Woodley Farra Manion Portfolio Management | $65.88M | 0.47 | 243,160 | +129.31% | +$37.15M | 3.63 | |
Bellevue Group | $62.24M | 0.45 | 229,697 | +5.48% | +$3.24M | 0.95 | |
Ubs Asset Management Americas Inc | $59.79M | 0.43 | 220,686 | +0.34% | +$201,044.90 | 0.02 | |
Citigroup | $54.9M | 0.39 | 202,617 | +11.51% | +$5.67M | 0.05 | |
Voya Investment Management LLC | $54.39M | 0.39 | 200,730 | -0.04% | -$19,237.45 | 0.06 | |
Boston Trust Walden Corp | $52.82M | 0.38 | 194,939 | -1.23% | -$655,699.00 | 0.38 | |
Fisher Asset Management Llc | $50.03M | 0.36 | 184,655 | -0.95% | -$479,852.73 | 0.02 |